Come up with a name for your new list and we'll add to it:
UMN Phrama raised a round of funding on , . Investors include
Mitsubishi UFJ Capital.
UMN-01, a anti-cancer product for which the company have licensed exclusive worldwide rights, is a small molecule down-regulator of GRP78, a 78 kDa glucose regulated protein that belongs to the HSP70 …